Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on beh ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
The approval of durvalumab, based on data from the phase 3 ADRIATIC study, offers a new standard of care for patients with ...
The 66th American Society of Hematology Annual Meeting & Exposition will take place December 7-10, 2024, in San Diego, ...
The presidency of Yoon Suk Yeol is in peril after his failed attempt to impose martial law triggered South Korea’s worst political crisis in years. At a meeting convened yesterday by Prime Minister ...
Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) -- including liver cancer, ...
Sweden's Wallenberg family wields immense influence, yet their name is little known. A closer look at the powerful family ...
The ISEQ All Share finished in the green, KOSPI down 1.44 per cent after martial law debacle ...
At the New York Times DealBook Summit, Mr Clinton was asked whether Mr Musk’s hostility to Mr Biden. Andrew Ross Sorkin, in ...
Enhertu won its initial China nod in early 2023 as a treatment for previously treated HER2-positive breast cancer and later ...
AstraZeneca on Wednesday named Iskra Reic as its new international executive vice president (EVP), taking over from Leon Wang ...
AstraZeneca Appoints Iskra Reic as International EVP Amid Chinese Investigation; Stock Down 3.8% YTD
AstraZeneca (AZN, Financials) named Iskra Reic as Executive Vice President for International Operations, succeeding Leon Wang ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback